Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipchronic
- Development stage
- Unknown
- Lead developer
- Forchronic
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Lipchronic is a bioactive nutritional formula developed by the IMDEA Food Institute, consisting of a supercritical extract of rosemary (*Rosmarinus officinalis* L.) rich in phenolic diterpenes (primarily carnosic acid and carnosol) formulated with bioactive alkylglycerols to enhance bioavailability. It is designed as a precision nutrition adjuvant for cancer patients undergoing chemotherapy, immunotherapy, or targeted therapies. Clinical studies (NCT05080920) have demonstrated its ability to modulate systemic inflammation, reduce the neutrophil-to-lymphocyte ratio (NLR), and preserve key immune cell populations like CD8+ memory T cells and monocytes, particularly in lung cancer patients. The formulation aims to counteract cancer-associated malnutrition and inflammation while potentially synergizing with standard oncological treatments.
- Brand names
- Lipchronic
- Other names
- LipLipchronic©Lipchronic®SFRE formulated with alkylglycerols
Beyond the preview
Go deeper on Lipchronic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipchronic.